Editas Medicine (EDIT) Earnings Date & Reports

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

EDIT is expected to report earnings to rise 39.33% to -20 cents per share on November 09

Editas Medicine EDIT Stock Earnings Reports

Q3'26

Est.

$-0.21

Q2'26

Beat

by $0.12

Q1'26

Beat

by $0.01

Q4'25

Beat

by $0.17

Q3'25

Beat

by $0.02

The last earnings report on August 05 showed earnings per share of -15 cents, beating the estimate of -27 cents. With 734.56K shares outstanding, the current market capitalization sits at 432.33M.

View a ticker or compare two or three

EDIT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days